Feb 24, 2022 / 08:30PM GMT
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior Analyst
Thank you for joining us here at the Citi Healthcare Conference. I'm Patrick Donnelly, the Citi analyst covering tools and diagnostics. Happy to have in our last session here, Waters CFO, Amol Chaubal.
We're going to cover about 35 minutes or 40 minutes of Q&A. Investors, if you have any questions, feel free. You can e-mail them over. I will try to get them asked. But I guess we can dive right in.
Questions and Answers:
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior AnalystI think as we talked about a minute ago, I think you guys gave some great color for '22 in terms of the building blocks and the algorithm of growth. Amol, maybe we can start on the instruments portfolio. You guys put up nice results last year.
Can you just talk through some of the growth drivers, the replacement initiative, maybe we can start there? Again, you guys kind of talked about continued opportunity in '22. What does that look like? And then again, what's
Trustpilot
